Annual reports from the research groups:

Unsal Tan O, Vagolu SK, Tønjum T, Kaplan O, Simsek R (2025)
Promising Antimycobacterial Agents: Salicylidenehydrazines
Arch Pharm (Weinheim), 358 (7), e70065
DOI 10.1002/ardp.70065, PubMed 40726231

Sverstad A, Møller JR, Virgili G, Azuara-Blanco A, Freiberg J, Ahrensberg S, Kristianslund O, Petrovski G, Kolko M (2025)
Central Contrast Sensitivity as an Outcome Measure in Randomized Controlled Trials in Glaucoma-A Systematic Review
Life (Basel), 15 (7)
DOI 10.3390/life15071043, PubMed 40724544

Goh BKP, Sucandy I, Chua DW, Liu Q, Edwin B, Aghayan D, Millet G, Ratti F, Zhang W, Scatton O, Coelho FF, Dokmak S, Mazzaferro V, Chiow AKH, Primavesi F, Ivanecz A, Choi SH, Lee JH, Prieto M, Vivarelli M, Giuliante F, Ruzzenente A, Yong CC, Yin M, Fondevila C et al. (2025)
Defining Global Benchmarks for Robotic Liver Resections: An International Multicenter Study
Ann Surg (in press)
DOI 10.1097/SLA.0000000000006852, PubMed 40720601

Dwt N, Leon De La Fuente R, Gallo P, Naesgaard P, Dib Ashur S, Michelsen AE, Aukrust P, Staines H, Ueland T (2025)
High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up
Int J Cardiol, 133674 (in press)
DOI 10.1016/j.ijcard.2025.133674, PubMed 40716679